(Q34228258)

31 July 2017

1 reference

title

Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement (English)

1 reference

31 July 2017

1 reference

5

Freedman J

1 reference

31 July 2017

Laupacis A

1

1 reference

31 July 2017

Brown J

2

1 reference

31 July 2017

Costello B

3

1 reference

31 July 2017

Delage G

4

1 reference

31 July 2017

Hume H

6

1 reference

31 July 2017

King S

7

1 reference

31 July 2017

Kleinman S

8

1 reference

31 July 2017

Mazzulli T

9

1 reference

31 July 2017

Wells G

10

1 reference

31 July 2017

1 April 2001

1 reference

31 July 2017

1 reference

31 July 2017

41

1 reference

31 July 2017

4

1 reference

31 July 2017

560-569

1 reference

Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Transfusion-acquired cytomegalovirus infection in neonates. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Infections Due to Herpesviruses in Cardiac Transplant Recipients: Role of the Donor Heart and Immunosuppressive Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

[Cytomegalo-virus infections in infants with blood exchange transfusions after birth].

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Acquisition of cytomegalovirus infection in infants following exchange transfusion: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Use of Deglycerolized Red Blood Cells to Prevent Posttransfusion Infection with Cytomegalovirus in Neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Cytomegalovirus Infection in Dialysis Patients and Personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Epidemiology of cytomegalovirus infection in end stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

Prevention of transfusion-transmitted cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41040560.X

10.1046/J.1537-2995.2001.41040560.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference